Day One of Wegovy: What the Evidence Says Will Happen

What the trial data showed about the first weeks of treatment

The STEP 1 trial (68 weeks, 1,961 adults with obesity or overweight and a weight-related condition) is the main evidence base for Wegovy 2.4 mg. Crucially for day one, the trial's titration schedule started at 0.25 mg for four weeks before any increase. That graduated approach was deliberate: researchers found it substantially reduced the rate of early discontinuation caused by nausea. The STEP 1 paper in the New England Journal of Medicine reported that gastrointestinal events were most common around dose escalations, not at the starting rung. What this means on day one: the medicine is working in the background, but most people feel very little.

Semaglutide acts on GLP-1 receptors that regulate appetite signals and slow gastric emptying. Both effects build gradually. If you want to understand what to expect from semaglutide day one, it helps to know that plasma levels are low and rising slowly on that first day, since the half-life is about a week and steady-state concentration is weeks away. You may notice a mild reduction in appetite at mealtimes, or nothing at all. That is normal and expected.

The NHS semaglutide medicines page notes that nausea is the most commonly reported early side effect, but for many people it does not appear until a dose increase, and for some it never arrives at all.

The practical side of your first injection

After your pen arrives, read the patient information leaflet before anything else. Keep the pen in the fridge (2–8°C) until the day of your injection; you can take it out 30 minutes before to bring it closer to room temperature, which many people find more comfortable. Check the dose window on the device and confirm the liquid is clear and colourless.

Choose your injection site (abdomen, thigh or upper arm) and clean the skin. Insert the needle, hold the pen firmly, and press the button until you hear a click. Keep it pressed for ten seconds to ensure the full dose is delivered. The starter pen delivers four weekly 0.25 mg doses, one per week. If you are unsure about any step, your Wegovy administration instructions and the PIL are the definitive reference; our prescribers are available seven days a week if questions come up.

Our guide to Wegovy day 1 covers exactly what to do after the injection, including how to note the day and time so you can keep a consistent weekly schedule from here on. A lot of people pick the same day as a weekly anchor: Sunday morning before the family wakes up, or Friday evening after work. Whatever you choose, same day each week from here on.

Side effects to be aware of, and what would need prompt attention

On day one of Wegovy, significant side effects are uncommon at 0.25 mg. If nausea does appear, it is usually mild and linked to eating a large or fatty meal. Eating smaller portions, avoiding very rich food and staying well hydrated all help. Light-headedness occasionally occurs; it usually settles within an hour.

The side effects that warrant same-day medical attention at any dose include severe or persistent abdominal pain that radiates to the back (a potential sign of pancreatitis, which the MHRA highlighted in its Drug Safety Update communications as a known though uncommon risk with GLP-1 medicines), signs of a serious allergic reaction such as facial swelling or breathing difficulty, and symptoms of dehydration if vomiting or diarrhoea are severe. None of these are common on day one, but knowing what to watch for is part of starting safely.

Injection-site redness, itching or a small lump are more likely early reactions. Rotating the site each week prevents them building up. If you have any concerns in the first 48 hours, our page on what to expect on day 2 of Wegovy is a useful next read, and our aftercare team is available seven days a week, so you are not left to figure it out alone.

What day one sets up for the weeks ahead

Starting at 0.25 mg means the first four weeks are about adaptation, not results. The titration schedule moves to 0.5 mg after week four, then 1.0 mg, 1.7 mg, and finally 2.4 mg, each step subject to clinical review to confirm tolerability. The Wegovy treatment overview explains the full pathway in detail.

Weight change tends to become noticeable from around weeks four to eight for most people, as appetite suppression takes hold and eating patterns shift. Day one is the necessary beginning of that arc, not the measure of it. The patients who do best treat the first injection as a process rather than a moment: they adjust their meals, keep moving, and check in with their prescriber when they have questions.

If you missed your first injection day or are unsure whether the dose was delivered fully, guidance on what to do when a Wegovy dose is late covers the practical steps. And if you are still weighing up whether this is the right treatment for your situation, our weight-loss treatment overview sets out how Wegovy compares with other licensed options. A free consultation with a GPhC-registered prescriber is the place to get a personalised clinical view; check your eligibility and start that conversation today.